Glucagon-like peptide-1 (GLP-1) medications are used to treat Type 2 diabetes, support chronic weight management, and more. In this video, learn the difference between compounded GLP-1s and branded GLP-1s, according to Stacia Woodcock, PharmD, Pharmacy Editor at GoodRx.
Stacia Woodcock, PharmD, is a pharmacy editor for GoodRx. She earned her Doctor of Pharmacy degree from the University of Kentucky and is licensed in New York and Massachusetts.
References
Ashraf, A. R., et al. (2024). Safety and risk assessment of no-prescription online semaglutide purchases. JAMA Network Open.
U.S. Department of Health and Human Services, et al. (2018). Compounded drug products that are essentially copies of a commercially available drug product under section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for industry.
U.S. Food and Drug Administration. (2024). Compounding when drugs are on FDA’s Drug Shortages List.
U.S. Food and Drug Administration. (2024). FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
U.S. Food and Drug Administration. (2025). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.
Why trust our experts?


Search and compare options









